OpenAlex
PricingAboutJobs
Log inGet started
Work

Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer.

PubMed

Year: 2009
Type: article
Source: PubMed
Authors: Yelena Krupitskaya, Heather A Wakelee
Institutions: Stanford Medicine, Stanford University
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: ramucirumab, VEGFR2, anti-angiogenic therapy, angiogenesis, vascular endothelial growth factor, monoclonal antibodies, hepatocellular carcinoma, renal cell carcinoma, ovarian carcinoma, melanoma, combination therapy, dose-limiting toxicity, hypertension, deep vein thrombosis
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W157457955
FWCI: 2.682
Cites:
Cited by: 109
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms